Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) - And amyloid beta 1-42-induced signal transduction in glial cells

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Slowik, Alexander ^a   Merres, Julika ^a   Elfgen, Anne ^a   Jansen, Sandra ^a   Mohr, Fabian ^a   Wruck, Christoph J ^a   Pufe, Thomas ^a   Brandenburg, Lars Ove ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Alzheimer disease; Amyloid beta 1 42; Astrocytes; Formyl peptide receptor; Glial cell; Microglia; RAGE; S100B; Signal transduction

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-42]; CYCLIC AMP; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 1; FORMYLPEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR LIKE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN S100B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MICROGLIA; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NEUROGLIA; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS MUSCULUS; RATTUS;

EID: 84869180626     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-55     Document Type: Article

References (46)

1. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. Selkoe DJ, J Alzheimers Dis 2001 3 75 80 12214075
2. Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. White JA, Manelli AM, Holmberg KH, Van Eldik LJ, Ladu MJ, Neurobiol Dis 2005 18 459 465 10.1016/j.nbd.2004.12.013 15755672
3. Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells. Parvathy S, Rajadas J, Ryan H, Vaziri S, Anderson L, Murphy GM Jr, Neurobiol Aging 2009 30 1792 1804 10.1016/j.neurobiolaging.2008.01.011 18339452
4. Abeta potentiates inflammatory activation of glial cells induced by scavenger receptor ligands and inflammatory mediators in culture. Murgas P, Godoy B, von Bernhardi R, Neurotox Res 2012 22 69 78 10.1007/s12640-011-9306-3 22237943
5. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. Sondag CM, Dhawan G, Combs CK, J Neuroinflammation 2009 6 1 10.1186/1742-2094-6-1 19123954
6. Neuroinflammation-an early event in both the history and pathogenesis of Alzheimer's disease. Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA, Neurodegener Dis 2010 7 38 41 10.1159/000283480 20160456
7. The significance of neuroinflammation in understanding Alzheimer's disease. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ, J Neural Transm 2006 113 1685 1695 10.1007/s00702-006-0575-6 17036175
8. Neuroinflammation in Alzheimer's disease and prion disease. Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, Williams A, Glia 2002 40 232 239 10.1002/glia.10146 12379910
9. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY, Neuroscience 2002 110 199 211 10.1016/S0306-4522(01)00460-2 11958863
10. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC, Wegiel J, Neurobiol Aging 2004 25 663 674 10.1016/j.neurobiolaging.2004.01.007 15172746
11. Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells. Brandenburg LO, Konrad M, Wruck CJ, Koch T, Lucius R, Pufe T, J Neurochem 2010 113 749 760 10.1111/j.1471-4159.2010.06637.x 20141570
12. Internalization of PrP106-126 by the formyl-peptide-receptor-like-1 in glial cells. Brandenburg LO, Koch T, Sievers J, Lucius R, J Neurochem 2007 101 718 728 17448144
13. Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells. Brandenburg LO, Konrad M, Wruck C, Koch T, Pufe T, Lucius R, Neuroscience 2008 156 266 276 10.1016/j.neuroscience.2008.07.042 18723082
14. The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis. Braun BJ, Slowik A, Leib SL, Lucius R, Varoga D, Wruck CJ, Jansen S, Podschun R, Pufe T, Brandenburg LO, J Neuroinflammation 2011 8 11 10.1186/1742-2094-8-11 21299846
15. Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. Alarcon R, Fuenzalida C, Santibanez M, von Bernhardi R, J Biol Chem 2005 280 30406 30415 10.1074/jbc.M414686200 15987691
16. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Paresce DM, Ghosh RN, Maxfield FR, Neuron 1996 17 553 565 10.1016/S0896-6273(00)80187-7 8816718
17. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, et al. Nature 1996 382 685 691 10.1038/382685a0 8751438
18. The macrophage receptor MARCO. Kraal G, van der Laan LJ, Elomaa O, Tryggvason K, Microbes Infect 2000 2 313 316 10.1016/S1286-4579(00)00296-3 10758408
19. The role of scavenger receptors in pathogen recognition and innate immunity. Mukhopadhyay S, Gordon S, Immunobiology 2004 209 39 49 10.1016/j.imbio.2004.02.004 15481139
20. Understanding RAGE, the receptor for advanced glycation end products. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP, J Mol Med 2005 83 876 886 10.1007/s00109-005-0688-7 16133426
21. Formyl-peptide receptors revisited. Le Y, Murphy PM, Wang JM, Trends Immunol 2002 23 541 548 10.1016/S1471-4906(02)02316-5 12401407
22. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. Bae YS, Lee HY, Jo EJ, Kim JI, Kang HK, Ye RD, Kwak JY, Ryu SH, J Immunol 2004 173 607 614 15210823
23. Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. Jankowsky JL, Younkin LH, Gonzales V, Fadale DJ, Slunt HH, Lester HA, Younkin SG, Borchelt DR, J Biol Chem 2007 282 22707 22720 10.1074/jbc.M611050200 17556372
24. S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Bianchi R, Giambanco I, Donato R, Neurobiol Aging 2008 31 665 677 18599158
25. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. McCarthy KD, de Vellis J, J Cell Biol 1980 85 890 902 10.1083/jcb.85.3.890 6248568
26. Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29. Brandenburg LO, Seyferth S, Wruck CJ, Koch T, Rosenstiel P, Lucius R, Pufe T, Mol Membr Biol 2009 26 371 383 10.1080/09687680903188340 19707939
27. Colocalization of fluorescent markers in confocal microscope images of plant cells. French AP, Mills S, Swarup R, Bennett MJ, Pridmore TP, Nat Protoc 2008 3 619 628 10.1038/nprot.2008.31 18388944
28. Image processing with ImageJ. Abramoff MDM, Paulo J, Ram, Sunanda J, Biophotonics international 2004 11 36 42
29. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W, Dunlop NM, Gao JL, Murphy PM, Oppenheim JJ, Wang JM, J Neurosci 2001 21 C123 11160457
30. Mechanism mediating oligomeric Abeta clearance by naive primary microglia. Yang CN, Shiao YJ, Shie FS, Guo BS, Chen PH, Cho CY, Chen YJ, Huang FL, Tsay HJ, Neurobiol Dis 2011 42 221 230 10.1016/j.nbd.2011.01.005 21220023
31. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model. Thanopoulou K, Fragkouli A, Stylianopoulou F, Georgopoulos S, Proc Natl Acad Sci U S A 2010 107 20816 20821 10.1073/pnas.1005888107 21076037
32. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Yan S, Schmidt AM, et al. FASEB J 2010 24 1043 1055 10.1096/fj.09-139634 19906677
33. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice. Vodopivec I, Galichet A, Knobloch M, Bierhaus A, Heizmann CW, Nitsch RM, Neurodegener Dis 2009 6 270 280 10.1159/000261723 20145420
34. The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes. Mulder SD, Veerhuis R, Blankenstein MA, Nielsen HM, Exp Neurol 2012 233 373 379 10.1016/j.expneurol.2011.11.001 22101005
35. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Valente T, Gella A, Fernandez-Busquets X, Unzeta M, Durany N, Neurobiol Dis 2010 37 67 76 10.1016/j.nbd.2009.09.008 19778613
36. RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Han SH, Kim YH, Mook-Jung I, Mol Cells 2011 31 91 97 10.1007/s10059-011-0030-x 21347704
37. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. Tiffany HL, Lavigne MC, Cui YH, Wang JM, Leto TL, Gao JL, Murphy PM, J Biol Chem 2001 276 23645 23652 10.1074/jbc.M101031200 11316806
38. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Rabiet MJ, Huet E, Boulay F, Biochimie 2007 89 1089 1106 10.1016/j.biochi.2007.02.015 17428601
39. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC, Perretti M, Flower RJ, J Immunol 2010 184 2611 2619 10.4049/jimmunol.0903526 20107188
40. Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Nielsen HM, Mulder SD, Belien JA, Musters RJ, Eikelenboom P, Veerhuis R, Glia 2010 58 1235 1246 20544859
41. Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S, Glia 2009 57 978 988 10.1002/glia.20822 19062178
42. Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease. Pan XD, Zhu YG, Lin N, Zhang J, Ye QY, Huang HP, Chen XC, Mol Neurodegener 2011 6 45 10.1186/1750-1326-6-45 21718498
43. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism. Betoin F, Ardid D, Herbet A, Aumaitre O, Kemeny JL, Duchene-Marullaz P, Lavarenne J, Eschalier A, J Pharmacol Exp Ther 1994 269 7 14 7909563
44. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S, J Biol Chem 2002 277 19762 19772 10.1074/jbc.M110373200 11896051
45. RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. Yan SD, Stern D, Kane MD, Kuo YM, Lampert HC, Roher AE, Restor Neurol Neurosci 1998 12 167 173 12671312
46. Microglia demonstrate age-dependent interaction with amyloid-beta fibrils. Floden AM, Combs CK, J Alzheimers Dis 2011 25 279 293 21403390